HyperStrong
海博思创
Elsewhere's corpus doesn't actually cover HyperStrong — there's no material in the retrieved set describing what it does, who founded it, or its funding. The closest match is a different company with a similar name: Hypershell (极壳科技), a consumer exoskeleton maker that closed two rounds totaling $70 million (Pre-B and B), with 绿洲资本 following on in both and over-committing in the Pre-B; its X Ultra is the first SGS-certified consumer exoskeleton, shipping to 70+ countries . If you meant HyperStrong specifically, the article list below is the extent of what's available.
AI-generated — may contain errors, please verify.
Coverage
Qiming Venture Partners Donates to Support Rescue and Reconstruction Efforts After Tibet Gyirong Mudslide Disaster
Supporting the Tibet Autonomous Region Charity Federation in disaster relief and post-disaster reconstruction efforts, providing emergency rescue and long-term assistance to affected populations.
Qiming Venture Partners Weekly: Top 10 Portfolio Company Updates Vol. 28, Sep. 2, 2026
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Star | Mech-Mind, Global Leader in Robot Brains, Successfully Lists on Hong Kong Exchanges and Clearing Limited | Bilingual
Qiming Venture Partners was the sole investor in Mech-Mind's Series A+ round in early 2019, and has been a partner to the company ever since.
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Vol.27, 2026.8.26
Celebrating milestone moments with Qiming Venture Partners' portfolio companies.
Xinguang completes 100 million yuan angel round led by Qiming Venture Partners
Dedicated to providing core optical interconnect products and next-generation full-stack optical interconnect solutions for global AI computing clusters, with the aim of becoming the defining force in optical interconnect technology for the world's AI infrastructure.
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Companies Vol.26, Aug. 18, 2026
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Star | Enginprime Medical Closes Nearly 100 Million Yuan Series A Round, Solely Invested by Qiming Venture Partners
J&T Global Express focuses on the percutaneous ventricular assist device (pVAD) track, dedicated to developing a new generation of small-size, high-flow ventricular assist systems.
Qiming Venture Partners' Alex Zhou: At the 'Everest Base Camp,' Foreseeing the Path to Kingship for AI Startups
Artificial intelligence is undergoing a profound shift from "bolt-on" to "built-in," from spectacle to commercial deployment.
Qiming Venture Partners and Portfolio Companies Win 2026 Golden Eagle Venture Capital and Sci-Tech Innovation Seedling Awards
Continuously identifying outstanding leaders in the venture capital and startup space, while witnessing entrepreneurial ventures grow from tender "new shoots" into towering trees.
Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Companies Vol.25, 2026.8.11
Following Qiming Venture Partners' portfolio companies as they hit milestone moments.
Qiming Star | Chinese Chassis-by-Wire Leader Nexteer Technology Successfully Lists on Hong Kong Exchanges and Clearing Limited
Qiming Venture Partners co-led NaSen Technology's Series A round in 2018 and continued to back the company in its Series B round.
Qiming Star | Immune-Mediated Disease Leader Attovia Therapeutics Debuts on Nasdaq | Bilingual
Focused on developing next-generation biotherapeutics for immune-mediated diseases with significant unmet clinical needs.
Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Companies Vol.24, 2026.8.4
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Morning Star | Spotlight Moment! Qiming Venture Partners and Portfolio Companies Win Major Awards at WAIC 2026
Including the 2026 AI Person of the Year, the Yunfan Award, the WAIC Future Tech α³⁵ Young Leaders list, the World Artificial Intelligence Conference's highest honor — the SAIL Award — as well as the "Treasure of the Pavilion" and other major award winners.
Blue Emergence raises tens of millions of RMB in angel+ round co-led by Qiming Venture Partners
Ocean-tech consumer products company
Morning Star | A Look Back: The Exhibits and Talks You Couldn't Get Enough of at WAIC 2026
Several portfolio companies of Qiming Venture Partners demonstrated their technological innovation capabilities and growth potential through forums, core technology showcases, and thought leadership on cutting-edge trends.
Qiming Venture Partners | WAIC Qiming Venture Partners Entrepreneurship and Investment Forum—The Evolution from Computing Power Origin to Application Success Held in Shanghai
As one of the most forward-looking and influential venture capital firms in artificial intelligence, Qiming Venture Partners has hosted this forum for four consecutive years. It is also the only forum at this year's World Artificial Intelligence Conference initiated by a venture capital firm, designed to showcase and explore the latest breakthroughs in AI's evolution from underlying computing power to industrial application — all through the lens of innovation.
Livestream Registration | Today! 2026 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum: The Evolutionary Journey from Computing Power Origin to Application Deployment
Decoding the Paradigm Shift in the LLM Era Together: How the Industry Can Move Beyond Pure Parameter Chasing to Ruthless Exploration of Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
One Day to Go: 2026 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum — The Evolution From Computing Power to Application Set to Open
Decoding the Paradigm Shift in the LLM Era: How the Industry Can Move Beyond Pure Parameter Chasing Toward Ruthless Exploration of Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
2 Days to Go: 2026 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum — The Evolution from Computing Power Origin to Application Deployment Set to Open
Decoding the Paradigm Shift in the LLM Era: How the Industry Can Move Beyond Parameter Chasing to Rigorously Explore Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
Guest Lineup Revealed | 2026 WAIC Qiming Venture Partners Entrepreneurship & Investment Forum: The Evolution from Computing Power Origin to Application Deployment
Decoding the Paradigm Shift in the Large Model Era: How the Industry Can Move Beyond Pure Parameter Chasing to Ruthless Exploration of Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
Agenda Unveiled | 2026 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum: The Evolutionary Journey from Computing Power Origin to Application Landing
Decoding the Paradigm Shift in the LLM Era: How the Industry Can Move Beyond the Pursuit of Parameters to Ruthlessly Explore Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
Qiming Weekly | 10 Updates from Qiming Venture Partners Portfolio Vol.23, 2026.7.7
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies.
Registration Open | Qiming Venture Partners Entrepreneurship and Investment Forum at 2026 WAIC: The Evolutionary Journey from Computing Power Origins to Application Deployment
Decoding the Paradigm Shift in the LLM Era: How the Industry Can Move Beyond Pure Parameter Chasing Toward Relentless Exploration of Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
Qiming Venture Partners Honored: Investor and Portfolio Founders Named to 36Kr Dark Current Waves 2026 36 Under 36 List
Spotlighting the transformative power of technology-driven industrial innovation, uncovering young leaders breaking through in deep-tech arenas like AI and advanced hardware.
Qiming Venture Partners Weekly | Top 10 Portfolio Company Updates Vol.22, June 30, 2026
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Its Investors Named to 36Kr China Equity Investment Annual Lists
Time only rewards those who truly understand what they're doing.
Qiming Weekly | Top 10 News from Qiming Venture Partners' Portfolio Companies Vol.21, 2026.6.23
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners' William Hu: Healthcare Investment Isn't About Hot or Cold Sectors—It's About Whether There's Enough Disruptive Potential
Someday, as China's economic and innovative strength grows, the value of Chinese entrepreneurs will naturally be reassessed.
Qiming Weekly | Qiming Venture Partners Portfolio News: Top 10 Updates Vol.20, June 16, 2026
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Qiming View | William Hu: Globalization of China's Healthcare Innovation Just Beginning, Will Be Investment Theme for Next 10-20 Years
China's healthcare innovation globalization has only just begun, and it will remain a sustained investment theme for the next 10-20 years.
Qiming Headlines: Intelligence Ignites the Future — Qiming Venture Partners' 17th RMB Fund Annual Meeting and Investor Summit Successfully Held in Shanghai
Qiming Venture Partners Maintains Investment Discipline, Proactively Captures Market Opportunities as Deal Flow Continues
Qiming Venture Partners Weekly | Top 10 Portfolio Company Updates Vol.19, June 9, 2026
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Dongsheng Fusion Raises $100 Million in New Funding Round, Co-Led by Qiming Venture Partners
J&T Global Express is committed to developing strong magnetic field compact fusion power plant technology using "deuterium-helium-3" as fuel.
Qiming View | Qiming Venture Partners' Kan Chen: Leading Two Consecutive Rounds for Ticen Biotech, Firmly Committed to Cutting-Edge Medical Innovation
Qiming Venture Partners remains steadfast in its focus on addressing unmet clinical needs and consistently pursues cutting-edge healthcare innovations with global competitiveness.
Qiming Venture Partners Portfolio Company Tiachen Biologics, a Leader in Allergy and Autoimmune Innovative Drugs in China, Successfully Lists on Hong Kong Exchanges and Clearing Limited
In 2024, Qiming Venture Partners led TianChen Bio's Series B2 round, and then co-led the company's Series C round in 2025.
Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Vol.18, 2026.6.2
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners' William Hu: China Is Seeing the Birth of a Wave of Global Pharmaceutical Companies
Over the next five to ten years, more highly original R&D breakthroughs are expected to emerge from labs in China and contribute to global pharmaceutical innovation.
Qiming View | Alex Zhou and Chen Nan of Qiming Venture Partners: Witnessing Yunyinggu Technology Team's Exponential Growth, Staying 'Half a Step Ahead' Through Long-Termism
Qiming Venture Partners' investment strategy is becoming increasingly focused, staying committed to deepening its existing circle of competence and building out its portfolio with steady, deliberate execution.
Morning Star | China Display Chip Design Leader Yunyinggu Technology Lists on Hong Kong Exchanges and Clearing Limited | Bilingual
As early as 2019, Qiming Venture Partners led Yunyinggu's Series C round and continued to back the company in its subsequent Series D financing.
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Companies Vol.17, 2026.5.26
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Nearly 40 Portfolio Companies Named to VBData 2026 Future Healthcare 100
China's most authoritative and influential innovation benchmark for the healthcare industry
Qiming Headlines | Qiming Venture Partners Healthcare Innovation Investment Team Launches 2026 PhD Summer Internship Program | Bilingual
In this 8–10 week internship program, you'll have the opportunity to work alongside some of the most innovative founders in biotech, health tech, and AI-powered healthcare — with dedicated growth opportunities built just for you.
Qiming Venture Partners' Wang Shiyu: AI App Explosion Needs a Huge Business Model Overhaul
The real explosion of consumer-facing AI applications may require a massive shift in business models to make it happen.
Qiming Venture Partners Weekly | Top 10 Portfolio Company Updates Vol.15, April 28, 2026
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies
Qiming Headlines | Qiming Venture Partners and Portfolio Companies Win Multiple Awards Including Top 4 on ChinaVenture's 2025 China Best VC Firms List
The "ChinaVenture Ranking" has been published for 20 consecutive years, and is known throughout the industry for its professionalism, authority, and rigor. It is regarded as a bellwether for China's equity investment industry and serves as an important reference for capital commitments from many large institutional LPs.
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Companies Vol.14, 2026.4.21
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies.
Qiming Venture Partners | Connecting World-Class Science with Top Investors: Second Round of Startup Proposals Open for Inaugural S2S China Symposium
We sincerely invite top scientists to visit the S2SChina website and submit proposals, embarking on an accelerated journey from the lab to entrepreneurship.
Qiming Venture Partners-backed precision proteomics leader Alamar Biosciences debuts on Nasdaq
Qiming Venture Partners led Alamar Biosciences' Series A round in 2020, and continued to back the company in its Series B and C rounds.
Qiming Venture Partners Portfolio Companies Dominate 2025 New Economy Top 500 List
This ranking systematically maps the landscape, growth momentum, and evolutionary trajectory of China's new economy enterprises.
OriCell Therapeutics Announces $110 Million Pre-IPO Round, Co-Led by Qiming Venture Partners
Global leader in innovative tumor immunotherapy
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Companies Vol.12, 2026.4.7
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies.
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Companies Vol.11, 2026.3.31
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Exclusively Leads Medway Medical's Series C Financing
a leading player in China's disposable endoscope market
Qiming Star | Tashi Zhihang CEO Yilun Chen Makes GTC Debut: Globally Unveils AWE 3.0, the First General-Purpose Embodied Large Model That Can Actually Work, Establishing New Path for Physical AI
AWE 3.0's design goals are clear and pragmatic — to get robots truly "out of the greenhouse, onto the job site, and capable of generalizing across tasks."
Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Companies Vol.10, 2026.3.24
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Its Investors Named to Diyixinsheng's 2025 China Investment Institutions and Individuals Rankings
Designed to unearth a genuine "founder's guide to fundraising, an LP's investment reference."
Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Vol.09, 2026.3.17
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Portfolio Company Female Leaders Win Multiple Awards
The list and its curation aim to celebrate women's contributions and achievements in China's equity investment sector and to the Chinese economy.
Qiming Venture Partners Weekly | Top 10 Portfolio News Vol.08, 2026.3.10
Staying with you through milestone moments at Qiming Venture Partners portfolio companies
Qiming Venture Partners Perspective: Deepening China Healthcare Innovation to Build Global Value Core
Let China's medical innovation achievements benefit the world, and make Chinese innovation a major driving force for global healthcare development.
Qiming Venture Partners Wishes You a Happy Lantern Festival of Harmony, Fulfillment, and Good Fortune
A New Year Dawns; Spring's Tidings Have Arrived
Qiming Venture Partners Co-Leads Nearly 100 Million Yuan Series C Round in Raincong Biotech
J&T Global Express has built a world-leading medical hydrogel technology platform, dedicated to providing innovative medical device solutions for major clinical scenarios such as tumor treatment.
Qiming Weekly: Top 10 Portfolio Company Updates, Vol. 06, Feb. 25, 2026
Staying with you through milestone moments for Qiming Venture Partners' portfolio companies
Qiming Venture Partners | Pusilihua Founder Professor Song Yangzhou Named to TIME100 Health 2026 List of World's Most Influential People in Health
In the official selection rationale released by TIME, the focus was on the extraordinary contributions that Professor Songyang Zhou and his team at Pusillabio have made in the field of tuberculosis detection.
Qiming Venture Partners Portfolio Company Zhipu AI Open-Sources GLM-5: From Code to Engineering, the Best Open-Source Model for the Agentic Engineering Era
On the authoritative global Artificial Analysis benchmark, GLM-5 ranks fourth worldwide and first among open-source models.
Qiming View | Three AI IPOs in First Weeks of Year: Qiming Venture Partners' Alex Zhou on Following Power Law, Betting on Long Slopes and Big Tracks in Tech
To Alex Zhou, an IPO is a staging ground — a place to face tougher challenges, build up strength and resources, and prepare to strike.
Qiming Venture Partners Weekly · Top 10 Portfolio News, Vol. 05, 2026.2.11
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Qiming Venture Partners | Global Top Biotech VCs Gather, First S2S China Symposium Startup Proposal Countdown Begins
Top scientists are invited to visit the S2SChina website and submit proposals, embarking on an accelerated journey from the lab to entrepreneurship.
Qiming Star | China's Edge AI Chip Leader Aixin Yuanzhi Debuts on Hong Kong Exchanges and Clearing Limited
Qiming Venture Partners led Aixin Yuanzhi's Pre-A funding round in early 2020, becoming the company's earliest investor, and continued to support the company's growth in two subsequent funding rounds.
Morning Star | Qiming Venture Partners and Investors Honored on Touzijia 2025 Annual Equity Investment List
Recognizing investment institutions and individuals who have demonstrated sustained commitment and achieved outstanding results in the equity investment industry over the past year.
Qiming Venture Partners Portfolio Company Northmed Technology Debuts on STAR Market
In 2020, Qiming Venture Partners led the Series C round for NorthSea Therapeutics and continued to support the company's growth in its Series D round.
Qiming Venture Partners' Zhang Ao: Six Years with NorthMed, Strong Confidence in China Healthcare Innovation Fundamentals
From Qiming Venture Partners' perspective, an increasing number of Chinese medical innovations are demonstrating internationally leading clinical value, and their global competitiveness is rapidly rising.
Qiming Venture Partners and Six Team Members Honored on LP CLUB 2025 Annual Rankings
Recognizing outstanding organizations and individuals who have forged ahead with remarkable achievements over the past year, setting new benchmarks for industry development.
Qiming Venture Partners Weekly: Top 10 Portfolio Company Updates, Vol. 04, Feb. 3, 2026
Celebrating milestone moments with you at Qiming Venture Partners' portfolio companies
Five AI IPOs in Seven Months, Qiming Venture Partners: Investing in AI Is the Biggest Certainty for China Over the Next Two Decades
Thirteen years, over 100 portfolio companies, covering the full AI industry chain.
Qiming Venture Partners and Its Investors Win Multiple Awards on China FOF Research Center 2025 Annual Rankings
This is intended to encourage outstanding institutions and talent in private equity fund-of-funds and the broader fund industry, and to promote the healthy development of equity investment.
Qiming Venture Partners Weekly: Top 10 Portfolio Company Updates Vol. 03, Jan. 27, 2026
Join us in celebrating milestone moments for Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Peking University Launch "Building Global Consensus on AI Guardrails" Initiative
Build a shared framework for dialogue among industry, professional communities, and policymakers based on common understanding, driving the formation of foundational international norms of conduct.
Seven Qiming Venture Partners Portfolio Companies Named to Cyzone 100 Future Unicorns List
Uncovering the Forces of Business Transformation Over the Next 3–5 Years
Qiming Weekly: 10 Portfolio Company Updates, Vol. 02, Jan. 20, 2026
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Wins Six Awards on TMTpost 2025 Annual Pioneer List
China's venture capital market has entered a recovery channel, buoyed by the flood of AI.
Qiming Venture Partners Weekly: Top 10 Portfolio Company Updates, Vol. 01, Jan. 14, 2026
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Qiming Venture Partners co-leads Zenitar's nearly 600 million yuan Series C round
late-stage clinical biotech company
Qiming Venture Partners' Alex Zhou: Zhipu AI's Successful IPO Is a Huge Confidence Boost for China's Long-Term Sectors
Qiming Venture Partners adheres to a "half-step ahead" investment methodology: positioning itself before a major wave coalesces into explicit consensus, yet not so early that it enters purely unconverged scientific exploration. This demands deep industry understanding from the firm and a powerful "radar" network to capture convergence signals.
Morning Star | Zhipu AI, a Pioneer and Leader in China's AGI, Successfully Lists on Hong Kong Exchanges and Clearing Limited | Bilingual
Qiming Venture Partners co-led Zhipu AI's Series B1 round in early 2022 — nearly a year before ChatGPT's release ignited the global large language model wave. It was this funding that enabled Zhipu AI to push through the R&D of its first 100-billion-parameter model, GLM. Qiming Venture Partners continued to back the company in its Series B2 and B4 rounds.
Qiming View | William Hu: China's Innovation Is Moving From Scattered Breakthroughs to Large-Scale, Comprehensive Advances
Over the next 5–10 years, more highly original R&D breakthroughs are expected to emerge from Chinese labs and contribute to global pharmaceutical innovation.
Qiming Venture Partners Investors Land on ChinaVenture 2025 Investor Rankings
A bellwether for China's equity investment industry and a key reference for major institutional LPs when making allocation decisions.
Qiming Venture Partners and Its Investors Win Seven Awards Including Top 10 Best IPO Investment Institutions of 2025 by IPO Zao Zhi Dao
We hope to highlight investment firms that were bolder in their early-stage bets and backed projects that exerted greater influence on their industries and the market at large.
Qiming Star | Biren Technology, Leading Domestic GPU Company, Successfully Lists on Hong Kong Exchanges and Clearing Limited | Bilingual
Qiming Venture Partners was one of Biren Technology's earliest and most steadfast supporters. When Biren Technology was founded in 2019, Qiming Venture Partners came in as a founding investor, leading the company's first funding round, and has continued to back the company's growth ever since.
Qiming Venture Partners Wins Eight Awards in Zero2IPO's 2025 Rankings, Including Third Place Among China's Top VC Firms
The ranking aims to provide a robust evaluation and reference framework for China's equity investment industry.
Qiming Venture Partners Portfolio Company Insilico Medicine Successfully Lists on Hong Kong Exchanges and Clearing Limited
In 2019, Qiming Venture Partners led Insilico Medicine's Series B financing and continued to back the company through its Series C and D rounds. Prior to the IPO, Qiming Venture Partners held approximately 7% of Insilico Medicine's shares, making it one of the company's most important institutional investors.
Qiming Venture Partners and Duane Kuang Win Shanghai Securities News 2025 Eagle Award for Finance
Select the institutions with outstanding annual performance
Qiming Venture Partners ESG | Qiming Venture Partners Rural Revitalization Entrepreneurship Support Program Selected as Global Best Poverty Reduction Case
Telling the world vivid stories of China's rural revitalization
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 45, 2025
Following the milestones of Qiming Venture Partners' portfolio companies, together with you.
Morning Star｜Noitom Robotics Closes Pre-A+ Round Led by Qiming Venture Partners
is a data company serving the Embodied Artificial Intelligence and humanoid robotics industry
Qiming Venture Partners Earns Five Spots on 2025 Forbes China Midas List
Identify and recognize 100 investors who have delivered strong performance over the past five years.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 44, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Wins Three Awards at China Securities Journal's 9th Private Equity Golden Bull Awards
The China Securities Journal's 9th Annual Golden Bull Awards for Equity Investment continue to spotlight "patient capital," emphasizing long-term value investing and hard-tech innovation while exploring diversified fund exit pathways.
Qiming Venture Partners and Duane Kuang Named to Jazzyear 2025 China Tech Industry Investment Rankings
The list aims to recognize investors and investment firms with outstanding performance and strong growth momentum in 2025, who have exerted profound influence on the development of China's tech industry.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 43, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Morning Star | Over 20 Qiming Venture Partners Portfolio Companies Win 30 Awards in Zero2IPO's 2025 VENTURE50
The VENTURE50 rankings are China's bellwether for high-growth enterprise investment.
Qiming Venture Partners Wins 36Kr 2025 China Best ESG Investment Firm
ESG has become a powerful anchor for venture capital firms seeking certainty and reshaping value.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 42, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies.
Qiming Venture Partners Named One of ChinaVenture's 2025 Most LP-Focused VC Firms in China
The "ChinaVenture Ranking" is regarded as a bellwether for China's equity investment industry and serves as an important basis for capital commitments from many large institutional LPs.
Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery
Qiming Venture Partners responded swiftly, providing tangible support to disaster-affected residents and fulfilling its corporate social responsibility.
Qiming Venture Partners Named to Yicai CFV Top 10 Equity Investment Firms
Financial value is the synthesis of institutional competitiveness, product innovation, human capital, and risk management within the financial industry and markets. It also serves as the micro-foundation for a nation's overall financial strength and stability.
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 41, 2025
Staying with you through milestone moments for Qiming Venture Partners portfolio companies
Qiming Venture Partners' Duane Kuang: Hong Kong Has Become a Key International Financing Channel for Hard-Tech Companies
Today, if companies are "born global," investment firms must evolve into institutions that are "born global" too.
Morning Star | Four Qiming Venture Partners Portfolio Companies Named to NetEase Future Awards 2025 Annual AI List
These companies and individuals are not only the focus of venture capital and industry attention, but have also largely shaped the trajectory of China's AI development.
Qiming Venture Partners Leads Nearly 100 Million Yuan Series B Round in Ronghe Medical, Ushering in New Era for Respiratory Interventional Therapy
Going forward, Ronghe Medical will continue to focus on the frontier of life sciences, deepening the expansion and integration of its core technology matrix, and dedicating itself to developing original medical device solutions with significant clinical value.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 40, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Morning Star | Eight Qiming Venture Partners Portfolio Companies Named to QbitAI Research Institute's 2025Q3 AI 100 Product Rankings
The flagship product list represents the leading players in the current landscape, while the innovation product list spotlights the seed candidates poised for future markets. Together, these two lists — spanning from comprehensive strength to breakthrough potential — sketch out a more three-dimensional and authentic map of AI products, offering industry participants and observers a set of reference-worthy benchmarks.
Yangli Pharma closes nine-figure RMB Series B round led by Qiming Venture Partners
Focused on developing first-in-class and best-in-class Class 1 innovative drugs with global intellectual property rights, with a focus on oncology and chronic disease therapeutics.
Aureka Biotechnologies Closes Tens of Millions of Dollars in Series A Funding to Accelerate AI-Powered Antibody Design and Innovative Pipeline R&D
A biotech company focused on generative AI-powered antibody drug development
Qiming Venture Partners' Portfolio Company WeRide, a Global Pioneer in L4 Autonomous Driving, Completes Dual Primary Listing on Hong Kong Exchanges and Clearing Limited
WeRide is the Chinese autonomous driving company with the broadest international footprint and the most comprehensive product portfolio, and it is also the only technology company in the world whose products hold autonomous driving permits in seven countries.
Morning Star | Weitao Biotech Raises Over 100 Million Yuan in Angel Round Led by Qiming Venture Partners
Innovative companies in the global in vivo cell therapy space
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 39, 2025
Staying with you to mark milestone moments for Qiming Venture Partners' portfolio companies
Qiming Healthcare Partnering Day 2025 Successfully Held in Shanghai, Fostering Partnerships Between Global Pharma Giants and Chinese Biotech Startups
This marks the fourth consecutive year that Qiming Venture Partners has hosted this event, which to date has facilitated hundreds of one-on-one meetings for over a hundred leading global pharmaceutical and investment companies, laying a solid foundation for expanding the scope and elevating the level of collaboration between enterprises.
Qiming Star | Changsen Pharma Raises Hundreds of Millions of Yuan in Series B+ Funding to Accelerate Clinical Research and Global Expansion of Core Pipeline
Changsen Pharma is dedicated to independently developing first-in-class, best-in-class innovative drugs with global intellectual property rights to address unmet clinical needs.
Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Vol. 38, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Beware of Fake VC Scams
"Private funds raise capital only from specific qualified investors who meet certain criteria." Qiming Venture Partners reminds all investors and entrepreneurs to stay vigilant, verify authenticity, and avoid financial losses.
Morning Star | WeRide Showcases L4 Autonomous Driving Scale at 2025 World Intelligent Connected Vehicles Conference
WeRide has always made safety its highest priority, embedding it into every step of technology R&D, testing and validation, and daily operations.
Qiming Venture Partners Portfolio Companies Make 2025 Beijing Top 100 Private Enterprise Rankings
The list aims to highlight trends in Beijing's private-sector economy and industrial distribution, identify a cohort of high-quality private enterprises that align with the "high-end, precision, and cutting-edge" economic structure and demonstrate leading, exemplary, and driving effects, and encourage and guide private enterprises in practicing new development concepts to promote high-quality growth.
Qiming Venture Partners Portfolio Companies WeRide and Cornerstone Robotics Named to Wealth China's Best Design List 2025
*Wealth* (Chinese edition) has compiled its annual *Wealth* China Best Design list for four consecutive years. This year's selected projects collectively present a profound dialogue between technology and humanity, highlighting the core value of human designers in the AI era — deep empathy and insight, defining complex problems, and imbuing technology with warmth and meaning.
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 37, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Qiming Venture Partners Wins Three Awards at China Venture Capital Research Institute's 2025 Golden Investment Awards
The awards aim to comprehensively recognize investment institutions that have achieved outstanding success in driving industry progress and creating social value over the past year.
Solemn Statement
Qiming Venture Partners and Over 10 Portfolio Companies Named to Diyixinsheng's 2025 China AI Industry Innovation Pioneer List
The ranking aims to provide comprehensive insight into the AI industry's current state, competitive landscape, application trends, and emerging opportunities — identifying exceptional companies that demonstrate cross-cycle resilience and high growth potential, and that have earned recognition from both investors and customers.
Qiming Venture Partners Exclusively Leads Makera's Pre-A Round
Makera is a pioneer in consumer-grade desktop CNC (Computer Numerical Control) technology
Qiming Venture Partners Portfolio Company Yunji Technology Debuts on Hong Kong Stock Exchange
In 2021, Qiming Venture Partners led the Series C round for Yunji Technology and continued to support the company's growth in subsequent funding rounds.
Qiming Venture Partners Weekly | Portfolio Company Funding and Updates Roundup Vol. 36, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Vol. 35, 2025
Staying with you through milestone moments at Qiming Venture Partners portfolio companies
Qiming Venture Partners Weekly | Portfolio Company Updates Vol. 34, 2025
Tracking milestone moments with you for Qiming Venture Partners' portfolio companies
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 30, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Rongzi China's Zhu Shan and Qiming Venture Partners' Duane Kuang on AI as the Biggest Paradigm Shift and the Next Generation of Classic Investment Cases
Despite the fierce competition in tech today, many niche segments remain underexplored. The AI space will give rise to ecosystem players on the scale of Xiaomi, creating new opportunities for both industry giants and startups.
Qiming Venture Partners Weekly | Portfolio Companies Funding and Updates Vol. 29, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies.
Guest Lineup Revealed | Register Now for 2025 WAIC Qiming Venture Partners · Entrepreneurship and Investment Forum — Venture Capital Enters AI Technology and Application Resonance Cycle
This sub-forum will showcase and explore the latest breakthroughs in AI technology and applications through the lens of innovation. Qiming Venture Partners will bring together leading scholars and top entrepreneurs in the field — from both the startup and investment perspectives — for four keynote speeches and four panel discussions.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 24, 2025
Following Qiming Venture Partners' portfolio companies and their milestone moments with you
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 21, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 20, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Weekly | Qiming Venture Partners Portfolio Companies: Funding and Updates Vol. 18, 2025
Staying with you through milestone moments for Qiming Venture Partners' portfolio companies
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 16, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Weekly | Portfolio News and Updates Vol. 14, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Roundup Vol. 13, 2025
Following Qiming Venture Partners' portfolio companies' milestone moments with you
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 12, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Qiming Venture Partners Weekly | Portfolio News and Updates Vol. 09, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners' new appointment sends a signal
The perfect candidate.
